Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice

Carcinogenesis

Volumn 30, Issue 10, 2009, Pages 1789-1795

  Lin, Patrick P ^a   Pandey, Manoj K ^a   Jin, Fenghua ^a   Raymond, A Kevin ^a   Akiyama, Haruhiko ^b   Lozano, Guillermina ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE MUTATION; GENE TARGETING; LIMB BUD; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA; SOFT TISSUE SARCOMA; TRANSGENIC MOUSE;

ANIMALS; CROSSES, GENETIC; GENE DELETION; GENES, P53; GENES, RETINOBLASTOMA; HETEROZYGOTE; HOMOZYGOTE; LIMB BUDS; MICE; MUTATION; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; SARCOMA, EXPERIMENTAL;

EID: 70349985246     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp180     Document Type: Article

References (28)

1. Kirsch,D.G. et al. (2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat. Med., 13, 992-997.
2. Sommer,G. et al. (2003) Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc. Natl Acad. Sci. USA, 100, 6706-6711.
3. Rubin,B.P. et al. (2005) A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E. Cancer Res., 65, 6631-6639.
4. Nakai,N. et al. (2008) A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J. Pathol., 214, 302-311.
5. Jacks,T. et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
6. Donehower,L.A. (1996) The p53-deficient mouse: A model for basic and applied cancer studies. Semin. Cancer Biol., 7, 269-278.
7. Li,F.P. et al. (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res., 48, 5358-5362.
8. Jacks,T. et al. (1992) Effects of an Rb mutation in the mouse. Nature, 359, 295-300[see comments].
9. Lee,E.Y. et al. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature, 359 288-294[see comment].
10. Clarke,A.R. et al. (1992) Requirement for a functional Rb-1 gene in murine development. Nature, 359, 328-330[see comment].
11. Draper,G.J. et al. (1986) Second primary neoplasms in patients with retinoblastoma. Br. J. Cancer, 53, 661-671.
12. Hu,N. et al. (1994) Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene, 9, 1021-1027.
13. Marino,S. et al. (2000) Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev., 14, 994-1004.
14. Martin,J.F. et al. (2000) Identification of a prx1 limb enhancer. Genesis J. Genet. Dev., 26, 225-229.
15. Logan,M. et al. (2002) Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis J. Genet. Dev., 33, 77-80.
16. Nakanishi,R. et al. (2008) Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J. Bone Miner. Res., 23, 271-277.
17. Soriano,P. (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet., 21, 70-71.
18. Zamurovic,N. et al. (2004) Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J. Biol. Chem., 279, 37704-37715.
19. Lengner,C.J. et al. (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol., 172, 909-921.
20. Berman,S.D. et al. (2008) Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc. Natl Acad. Sci. USA, 105, 11851-11856.
21. Walkley,C.R. et al. (2008) Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev., 22, 1662-1676.
22. Stein,G.S. et al. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene, 23, 4315-4329.
23. Galindo,M. et al. (2005) The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem., 280 20274-20285.
24. Cserjesi,P. et al. (1992) MHox: A mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development, 115, 1087-1101.
25. Leussink,B. et al. (1995) Expression patterns of the paired-related homeobox genes MHox/Prx1 and S8/Prx2 suggest roles in development of the heart and the forebrain. Mech. Dev., 52, 51-64.
26. Knudson,A.G.Jr (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
27. Berman,S.D. et al. (2008) The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development. Mol. Cancer Res., 6, 1440-1451.
28. Gutierrez,G.M. et al. (2008) Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice. Proc. Natl Acad. Sci. USA, 105, 18402-18407.